Stonex CRO Maurer Sells $6.2m in Shares as Stock Hits Record

Stonex Group Inc. disclosed a series of open-market share sales by its chief risk officer, Michael Maurer, on June 17. The transactions, which were reported via SEC filings, totaled approximately $6.2 million. The sales occurred as the company's stock price reached an all-time intraday high of $124.75, a level not seen since the firm's initial public offering. Investing.com reported the regulatory filing on June 17, 2026.

Context — why this matters now

The sale coincides with a period of elevated market volatility, measured by the VIX index holding above 17 for the past month. Stonex, a global financial services network, has seen its stock price appreciate over 45% year-to-date. This significantly outpaces the S&P 500's 8% gain in the same period. The sustained rally follows several quarters of strong performance in the firm's physical commodities and foreign exchange trading desks.

Executives at Stonex have a history of selling shares around price peaks. In August 2025, another senior executive sold shares worth $3.8 million when the stock surpassed $115 for the first time. The current transaction by the chief risk officer, who is responsible for overseeing the firm's market and credit risk exposure, is the largest single executive sale at Stonex in the last 18 months. The sale is likely a pre-planned transaction under SEC Rule 10b5-1, which allows insiders to schedule sales in advance.

Data — what the numbers show

Michael Maurer sold 50,000 shares across multiple transactions on June 17. The sales were executed at prices between $123.10 and $124.75. The total proceeds of $6.2 million represent a sale of roughly 22% of Maurer's directly held Class A common stock, according to the filing. His remaining stake is now valued at approximately $21.5 million based on the closing price.

The sale price range represents a significant premium to the stock's 200-day moving average of $106.42. Stonex's market capitalization now stands at $4.8 billion. The stock's forward price-to-earnings ratio is 11.2, compared to a sector median of 14.5 for capital markets firms. The table below shows the sale price progression versus key benchmarks.

Metric	Value	Comparison to Sector
Sale Price Range	$123.10 - $124.75	N/A
Stock's YTD Return	+45%	Sector Median: +12%
Forward P/E Ratio	11.2	Sector Median: 14.5
VIX Index Level	17.4	1-Year Average: 15.8

Analysis — what it means for markets / sectors / tickers

The sale could signal a tactical view from the CRO that the stock's current valuation fully reflects near-term earnings potential. It may prompt short-term profit-taking among institutional holders, potentially creating selling pressure on tickers like SPGI and MCO, which have also seen extended runs. Gains could rotate into more defensive financial services names like Bank of New York Mellon (BK), which trades at a lower earnings multiple.

The clear limitation is that this is likely a pre-scheduled 10b5-1 plan sale, not a direct signal of corporate distress. Such plans are often established months in advance to avoid accusations of trading on inside information. The alternative view is that this is a routine portfolio rebalancing by a long-tenured executive. Position data from CFTC reports shows asset managers increased net long positions in Stonex futures by 15% in the week preceding the sale, indicating strong institutional conviction that may offset any negative signal.

Outlook — what to watch next

Stonex is scheduled to report its fiscal third-quarter earnings on July 24, 2026. Analysts' consensus estimates project earnings per share of $2.85, a 20% year-over-year increase. The key level to watch on the stock chart is $118, which represents the 50-day moving average and a previous resistance zone. A break below this level on elevated volume could indicate the bullish trend is weakening.

The next major catalyst is the Federal Open Market Committee meeting on June 18. Any shift in the Fed's rate trajectory will directly impact Stonex's core businesses in forex and commodities trading. Watch for commentary on commercial real estate exposure during the earnings call, as this is a sector where Stonex has significant brokerage and financing operations.

Frequently Asked Questions

What is a 10b5-1 trading plan?

An SEC Rule 10b5-1 trading plan allows corporate insiders to set up a predetermined schedule for buying or selling company stock. These plans must be established when the insider is not in possession of material non-public information. The plans specify amounts, prices, and dates, or use a written formula. This mechanism is designed to prevent accusations of insider trading by automating transactions, which is why large sales like Maurer's are often executed under such a plan.

How does Stonex's valuation compare to peers like Charles Schwab?

Stonex trades at a discount to larger, more diversified brokerage peers. Its forward price-to-earnings ratio of 11.2 is below Charles Schwab's (SCHW) 14.8 and Interactive Brokers' (IBKR) 16.1. This discount reflects Stonex's focus on institutional and commercial clients in physical commodities and forex, which are seen as more cyclical businesses than retail wealth management. Stonex's return on equity of 18% for the last quarter, however, exceeds the peer average of 15%.

What are the tax implications of an executive stock sale of this size?

For an executive like Maurer, the sale of vested shares typically triggers a capital gains tax event. The tax rate depends on the holding period. Shares held for over one year qualify for the long-term capital gains rate, currently 20% for high-income earners, plus a 3.8% Net Investment Income Tax. Shares acquired via options or restricted stock units may have different cost bases and holding periods, creating a complex tax liability that often necessitates pre-planned sales to cover the obligation.

Bottom Line

The CRO's sale is a large but likely pre-planned monetization event during a period of peak valuation, not an immediate signal of operational risk.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.